Rosenblut Andres, Napolitano Carla, Pereira Angelica, Moreno Camilo, Kolhe Devayani, Lepetic Alejandro, Ortega-Barria Eduardo
Unidad de Otorrinolaringología, Hospital Sótero del Rio, Puente Alto, Santiago, Chile Merck & Co, Sao Paulo, Brazil; at the time of the study Takeda Pharmaceuticals, Sao Paulo, Brazil GSK Pharmaceuticals Ltd, Bangalore, India GSK Buenos Aires, Argentina GSK Panama, Panamá.
Medicine (Baltimore). 2017 Feb;96(6):e5974. doi: 10.1097/MD.0000000000005974.
The impact of bacterial conjugate vaccines on acute otitis media (AOM) is affected by several factors including population characteristics, bacterial etiology and vaccine conjugation method, carrier, and coverage. This study estimated the baseline etiology, distribution, and antibiotic susceptibility of bacterial serotypes that causes AOM in children aged <5 years in a public setting in Santiago, Chile.Children aged ≥3 months and <5 years referred to the physician for treatment of AOM episodes (with an onset of symptoms <72 h) were enrolled between September 2009 and September 2010. Middle ear fluid (MEF) was collected by tympanocentesis or by otorrhea for identification and serotyping of bacteria. Antibacterial susceptibility was tested using E-test (etrack: 112671).Of 160 children (mean age 27.10 ± 15.83 months) with AOM episodes, 164 MEF samples (1 episode each from 156 children; 2 episodes each from 4 children) were collected. Nearly 30% of AOM episodes occurred in children aged 12 to 23 months. Streptococcus pneumoniae (41.7% [58/139]) and Haemophilus influenzae (40.3% [56/139]) were predominant among the cultures that showed bacterial growth (85% [139/164]). All Streptococcus pneumoniae positive episodes were serotyped, 19F (21%) and 14 (17%) were the predominant serotypes; all Haemophilus influenzae strains were nontypeable. Streptococcus pneumoniae were resistant to penicillin (5%) and erythromycin (33%); Haemophilus influenzae were resistant to ampicillin (14%) and cefuroxime and cefotaxime (2% each).AOM in Chilean children is predominantly caused by Streptococcus pneumoniae and nontypeable Haemophilus influenzae. Use of a broad spectrum vaccine against these pathogens might aid the reduction of AOM in Chile.
细菌结合疫苗对急性中耳炎(AOM)的影响受多种因素影响,包括人群特征、细菌病因以及疫苗结合方法、载体和覆盖范围。本研究估计了智利圣地亚哥公共环境中5岁以下儿童AOM致病细菌血清型的基线病因、分布及抗生素敏感性。2009年9月至2010年9月期间,纳入了年龄≥3个月且<5岁、因AOM发作(症状发作<72小时)而转诊至医生处治疗的儿童。通过鼓膜穿刺术或耳漏收集中耳液(MEF),用于细菌鉴定和血清分型。使用E-test(etrack:112671)检测抗菌药敏性。在160例有AOM发作的儿童(平均年龄27.10±15.83个月)中,收集了164份MEF样本(156名儿童每人1次发作;4名儿童每人2次发作)。近30%的AOM发作发生在12至23个月大的儿童中。在有细菌生长的培养物(85%[139/164])中,肺炎链球菌(41.7%[58/139])和流感嗜血杆菌(40.3%[56/139])占主导。对所有肺炎链球菌阳性发作进行了血清分型,19F(21%)和14型(17%)是主要血清型;所有流感嗜血杆菌菌株均为不可分型。肺炎链球菌对青霉素耐药(5%),对红霉素耐药(33%);流感嗜血杆菌对氨苄西林耐药(14%),对头孢呋辛和头孢噻肟耐药(各2%)。智利儿童的AOM主要由肺炎链球菌和不可分型的流感嗜血杆菌引起。针对这些病原体使用广谱疫苗可能有助于减少智利AOM的发生。